Randomized phase III clinical trials demonstrate that combination chemotherapy regimens containing antracyclines offer superior survival compared to monochemotherpy or combination regimens not containing antracyclines. Antracycline re-challenge has become a consolidated practice in the clinical management of patients with metastastic disease.
Re-challange con doxorubicina liposomiale non pegilata in paziente con carcinoma mammario in ripresa di malattia
MALLAMACI, Rosanna
2015-01-01
Abstract
Randomized phase III clinical trials demonstrate that combination chemotherapy regimens containing antracyclines offer superior survival compared to monochemotherpy or combination regimens not containing antracyclines. Antracycline re-challenge has become a consolidated practice in the clinical management of patients with metastastic disease.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
